Fixing the Impossible
24/7 (202) 973-1300   

Richard Levick in WSJ

Share on facebook
Share on twitter
Share on linkedin

Richard Levick was recently quoted in the Wall Street Journal on Mylan’s handling of the EpiPen crisis:

“It™’s not good when a corporate crisis gets its own hashtag and thousands of people begin using it. It™’s even worse when that hashtag ends in ‘gate.’ Yet Mylan™’s handling of its EpiPen pricing issue–#Epigate as it was tagged by one parent/activist–is hardly scandalous. In truth, once it became a news story three days after #Epigate was coined, Mylan deserves reasonably high marks for its response.  Its messaging and strategy were solid. It offered a discounted purchasing plan. It took the dramatic step of developing a generic alternative to make EpiPen more affordable. Its chief executive assumed public responsibility and made herself accessible to the media.”

 

More Posts